SCHEMBL110464

SCHEMBL110464

CCCCOC(=O)C(C)(C)CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
ATM Q13315 1/20 0.48
TSHR P16473 5/20 0.45
HPGD P15428 1/20 0.45
HCAR2 Q8TDS4 1/20 0.42
NAAA Q02083 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
EPHX1 P07099 1/20 0.39
LMNA P02545 1/20 0.39
ESR1 P03372 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
NR1H2 P55055 1/20 0.39
RNASEL Q05823 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2680624 0.94 NAAA (0.50) ALDH1A1ATMTSHRHCAR2NAAA
SCHEMBL10141464 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1
SCHEMBL17151524 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1
SCHEMBL10050676 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1
SCHEMBL10349281 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1
SCHEMBL12858360 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1
SCHEMBL2680512 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1
SCHEMBL2681108 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1
SCHEMBL10141466 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1
SCHEMBL10141469 0.92 NAAA (0.53) ALDH1A1TSHRHCAR2NAAAEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 602 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105255246-B Finish compositions and photolithography method 罗门哈斯电子材料有限公司 2019-08-13 CN claimed
CN-103319521-A Cyclic siloxane compositions for the release of active ingredients GEN ELECTRIC 2013-09-25 CN claimed
CN-102695491-A Perfumes and perfume encapsulates PROCTER & GAMBLE 2012-09-26 CN claimed
US-20260109796-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2026-04-23 US disclosed
US-20260110920-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2026-04-23 US disclosed
EP-4435080-B1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE (US) 2025-08-20 EP disclosed
US-12371642-B2 Benefit agent containing delivery particle THE PROCTER & GAMBLE COMPANY (US) 2025-07-29 US disclosed
EP-3955900-B1 POLYMERIC CAPSULES PROCTER & GAMBLE (US) 2025-07-23 EP disclosed
WO-2025056470-A1 AQUEOUS-BASED PERFUME COMPOSITION JAFER ENTERPRISES R&D SL (ES) 2025-03-20 WO disclosed
US-20240316523-A1 PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE COMPANY, THE 2024-09-26 US disclosed
EP-4435080-A1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE The Procter & Gamble Company (US) 2024-09-25 EP disclosed
US-20070065394-A1 Compositions effective in altering the perception of malodor PATUS LTD. (IL) 2007-03-22 US disclosed
US-20070059639-A1 Positive resist composition and pattern-forming method using the same FUJI PHOTO FILM CO., LTD. 2007-03-15 US disclosed
US-20070046719-A1 Image forming apparatus FUJI PHOTO FILM CO., LTD. 2007-03-01 US disclosed
US-7179582-B2 Radical polymerizable composition and lithographic printing plate precursor using the same FUJI PHOTO FILM CO., LTD. (JP) 2007-02-20 US disclosed
US-20070037103-A1 BISPHENOL COMPOUND AND PHOTOTHERMOGRAPHIC MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-02-15 US disclosed
US-20070031757-A1 Positive photosensitive composition and method of pattern formation with the same FUJI PHOTO FILM CO., LTD. 2007-02-08 US disclosed
US-20070026343-A1 Chemical amplification-type resist composition and production process thereof FUJI PHOTO FILM CO., LTD. 2007-02-01 US disclosed
WO-2005046632-A9 COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR PATUS LTD (IL) 2005-09-22 WO disclosed
WO-2005046632-A2 COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR PATUS LTD. (IL) 2005-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260110920-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES ERCC1, ERCC5, ERCC4 ALDH1A1 3021/4885ATM 203/4885TSHR 2920/4885
US-20260109796-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES ERCC1, PDE6H, HCK ALDH1A1 2416/4885ATM 478/4885TSHR 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.